News
Leading pharmaceutical company invests in seven-figure state-of-the-art facility
Huddersfield pharmaceutical company Thornton & Ross is expanding, with a new seven-figure state-of-the-art facility due to open at the beginning of January.
Thornton & Ross triumphant in industry awards
Huddersfield-based pharmaceutical company Thornton & Ross has received national recognition for six of its products at the national 2019 ‘Most Valuable Product’ (MVP) Awards in pharmacy.
Thornton & Ross launches alternative, cost-effective treatment for osteoporosis in UK
West Yorkshire-based pharmaceutical company Thornton & Ross (T&R) is launching an alternative, cost-effective treatment for osteoporosis.
Thornton & Ross to acquire established GSK Consumer Health brands
Thornton & Ross has expanded its Consumer Health business with a contract to acquire four UK skin care brands, as well as a paediatric cough remedy, from GlaxoSmithKline. Completion of the deal is expected to occur by August 2019.
Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO
STADA Arzneimittel AG Appoints Peter Goldschmidt as CEO to suceed Claudio Albrecht.
STADA acquires EMEA rights to global anti-dandruff brand Nizoral from Janssen Pharmaceutica
STADA Arzneimittel AG is further strengthening its position in branded over-the-counter healthcare products.
Ladival wins 'Best Beach Sun Protection 2017'
Thornton & Ross is pleased to announce that Ladival Sun Protection Lotion SPF30 has won the 'Best Beach Sun Protection' in this year's Best Beauty by Stylist Awards 2017.
Thornton & Ross Ltd signs licensing agreement with Futura Medical
Thornton & Ross is pleased to announce it has entered in to a long-term licensing agreement with Futura Medical.
>> News Archive